Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-014373
Filing Date
2022-03-01
Accepted
2022-03-01 19:28:00
Documents
1
Period of Report
2022-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5915
  Complete submission text file 0001209191-22-014373.txt   7323
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Issuer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O POSEIDA THERAPEUTICS, INC. 4242 CAMPUS POINT COURT, SUITE 700 SAN DIEGO CA 92121
Business Address
Spear Matthew A. (Reporting) CIK: 0001766302 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39376 | Film No.: 22700619